• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Small sprouting plant starting to grow
Biotech

Aspen's Parkinson's cell therapy data plant seeds for ph. 3

Eight out of eight patients saw marked improvements in measures of symptom control, motor function and quality of life one year after treatment.
Darren Incorvaia Mar 18, 2026 9:00am
Living cells illustration Cells membrane with nucleus are floating Medical and science concept background 3D render

After $1B fundraise, Xaira breaks silence on AI work

Mar 17, 2026 2:52pm
Shutterstock 244923752png

Stop asking for an AI strategy: 3 questions clinical leaders should ask instead

Brought to you by Syneos Health
macaque monkeys

FDA, NIH pledge flexibility and $150M for animal alternatives

Mar 18, 2026 9:00am
How physiology powers biotech innovation

How physiology powers biotech innovation

Brought to you by American Physiological Society
Crossbow

Crossbow hits $77M series B round to bankroll quiver of T-Bolts

Mar 18, 2026 10:50am
More News

Stroke tech developer Imperative Care nets $100M financing

Mar 18, 2026 10:50am

Fierce Biotech Fundraising Tracker '26: Crossbow, R1 & more

Mar 18, 2026 10:30am

JenaValve secures FDA's 1st approval in aortic regurgitation

Mar 18, 2026 10:05am

Fierce Biotech Layoff Tracker 2026: Gossamer, Bicycle & more

Mar 18, 2026 9:00am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings